M2 Pharma - Therapy Areas

Humanetics Expands Long-Haul COVID-19 Trial

19 May 2022 - - US-based clinical-stage pharmaceutical company Humanetics Corp has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated fo...

PDS Biotechnology names senior vice president Business Development

19 May 2022 - PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease v...

China's BeiGene Opens Regional Office in Basel, Switzerland

18 May 2022 - - Chinese biotechnology company BeiGene, Ltd. (NASDAQ: BGNE) (HKEX: 06160) (SSE: 688235) has opened a new regional office in Basel, Switzerland, the company said.

BeiGene sa...

Vraniak Named Chief Financial Officer at Inversago Pharma

18 May 2022 - - Canadian clinical stage biotechnology company Inversago Pharma Inc., which has a portfolio of CB1 inverse agonists, has appointed Glenn S. Vraniak to the position of chief financial of...

New data from Sanofi's oncology pipeline and portfolio to be presented at 2022 ASCO Annual Meeting

18 May 2022 - French multinational healthcare company Sanofi announced on Tuesday that new research that is to be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting from...

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland Join List of Canadian Provinces Providing Public Drug Plan Reimbursement for Teva Canada's Ajovy for the Preventive Treatment of Migraine in Adults

18 May 2022 - - Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) (TASE: TEVA) Teva Canada Ltd subsidiary of., welcomes the recently announced public formulary cove...